Pulse एक्सप्लोर nav.journalClub बहसें ट्रेंडिंग शोधकर्ता

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

होम एक्सप्लोर nav.journalClub ट्रेंडिंग

⌘+K

March 14, 2026Open Access

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis

Key Points

To evaluate long-term adherence to Elexacaftor/Tezacaftor/Ivacaftor (ETI) and Ivacaftor (IVA) in patients with cystic fibrosis.
Analyzed pharmacy refill data over three years
Monitored adherence to ETI and IVA
Calculated adherence rates at multiple time points
High adherence to ETI and IVA observed initially
Adherence levels declined over the three-year period
Refill data indicated consistent patterns of medication usage

Abstract

Three-year adherence to ETI and IVA based on pharmacy refill data was high, yet declined over time.

AI से पूछें

Like

Bookmark

Share

View Full Paper

AI से पूछें

Like

Bookmark

Share

View Full Paper

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis | Synapse

Cite This Study

Hansen et al. (Wed,) studied this question.

synapsesocial.com/papers/69b4fc44b39f7826a300d131 https://doi.org/https://doi.org/10.1007/s41030-026-00351-4